NKTR Drug delivery Company Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company

NKTR 59.32

+2.3%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: dr.praveen who wrote (277)	10/23/2007 7:18:25 PM
From: Arthur Radley	Read Replies (1) of 507

Give the chairman an A+ for candor....... By Ransdell Pierson NEW YORK, Oct 23 (Reuters) - The chairman of Alkermes Inc. (ALKS.O: Quote, Profile, Research) said on Tuesday his company's Air Insulin device had convenience advantages over Pfizer Inc's (PFE.N: Quote, Profile, Research) abandoned Exubera, but said all forms of inhaled insulin will likely have the same tendency to slightly impair lung function.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next